Every record from Janoshik · page 31
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020588 | Semaglutide | SSA | SSA-2509-J7266 | 2025-Q4 | 97.42 | 6.74 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019803 | L-Glutathione (reduced) | HJ | HJ-2511-L3998 | 2025-Q4 | 99.02 | 8.40 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021211 | Gonadorelin | BCH | BCH-2510-F6239 | 2025-Q4 | 98.91 | 5.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020835 | Epitalon | SGN | SGN-2511-G1523 | 2025-Q4 | 99.56 | 8.80 | — | Supplier-supplied | 0 | FAIL |
| AX-2025-020464 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 99.06 | 5.16 | 104.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020442 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 99.18 | 2.55 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020077 | Semaglutide | ERP | ERP-2509-A8587 | 2025-Q4 | 98.39 | 5.74 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019783 | Ipamorelin | HJ | HJ-2511-D4010 | 2025-Q4 | 99.43 | 3.49 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019619 | Melanotan II | Homopeptide | HOMO-2508-A1964 | 2025-Q4 | 99.24 | 6.06 | 97.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019575 | Semaglutide | Homopeptide | HOMO-2509-F1941 | 2025-Q4 | 99.73 | 5.32 | 107.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018758 | TB-500 | QSC | QSC-2505-C7889 | 2025-Q4 | 98.54 | 3.52 | 94.1 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018597 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.17 | 4.43 | 95.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019582 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.93 | 6.25 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019392 | Retatrutide | Homopeptide | HOMO-2508-Y8363 | 2025-Q4 | 97.66 | 7.15 | 88.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019054 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B3061 | 2025-Q4 | 99.25 | 4.80 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019024 | N-Acetyl Semax Amide | JEEP | JEEP-2507-U3035 | 2025-Q4 | 99.92 | 8.23 | 90.3 | Supplier-supplied | 0 | PASS |
| AX-2025-018705 | GHRP-6 | QSC | QSC-2508-F6725 | 2025-Q4 | 99.93 | 4.44 | 90.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021131 | Semaglutide | WXT | WXT-2509-A5382 | 2025-Q4 | 98.41 | 6.17 | 102.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020587 | Semaglutide | SSA | SSA-2509-J7266 | 2025-Q4 | 97.33 | 6.88 | 107.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020470 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.73 | 5.13 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020409 | Tirzepatide | KP | KP-2505-F4869 | 2025-Q4 | 96.41 | 5.01 | 97.7 | Laboratory-retained | 1 | FAIL |
| AX-2025-020868 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 98.08 | 6.57 | 106.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020213 | Desmopressin | GGPeps | GGPE-2511-Y1573 | 2025-Q4 | 99.36 | 3.52 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019897 | Selank | SWB | SWB-2511-C5170 | 2025-Q4 | 98.68 | 8.82 | 93.3 | Buyer-sourced | 0 | FAIL |
| AX-2025-019435 | Melanotan II | Homopeptide | HOMO-2505-N9201 | 2025-Q4 | 98.70 | 2.61 | 91.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020910 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.93 | 7.00 | 103.6 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020907 | GHRP-6 | CPC | CPC-2507-G2066 | 2025-Q4 | 99.65 | 5.87 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020158 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.73 | 7.04 | 99.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020157 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.43 | 7.34 | 93.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019929 | IGF-1 LR3 | SWB | SWB-2505-N5257 | 2025-Q4 | 97.17 | 6.54 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019926 | IGF-1 LR3 | SWB | SWB-2505-N5257 | 2025-Q4 | 96.90 | 6.74 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018582 | BPC-157 | QYB | QYB-2506-B4999 | 2025-Q4 | 99.93 | 4.66 | 91.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021101 | Semaglutide | WXT | WXT-2507-N4828 | 2025-Q4 | 98.12 | 4.78 | 96.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020450 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 99.48 | 2.32 | 89.5 | Supplier-supplied | 2 | FAIL |
| AX-2025-019870 | L-Glutathione (reduced) | SWB | SWB-2506-B5296 | 2025-Q4 | 98.96 | 9.86 | 91.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019636 | Semaglutide | Homopeptide | HOMO-2508-K2535 | 2025-Q4 | 99.20 | 3.94 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021236 | AOD-9604 | BCH | BCH-2509-K6299 | 2025-Q4 | 98.68 | 4.31 | 106.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021210 | Gonadorelin | BCH | BCH-2510-F6239 | 2025-Q4 | 99.02 | 5.73 | 104.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020634 | Semaglutide | SSA | SSA-2510-C7247 | 2025-Q4 | 98.26 | 4.06 | 97.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020341 | BPC-157 | MKM | MKM-2506-D3139 | 2025-Q4 | 98.94 | 3.36 | 94.3 | Supplier-supplied | 1 | MARGINAL |